Latest therapeutics News | Page 3

$15 million for research to better treat prostate and childhood cancer
$15 million for new cancer fighting research centre
Arovella Therapeutics licences monoclonal antibody for cell therapy development
Targeting unsuspected protein reverses lymphedema
Research reveals how disordered proteins contribute to the properties of the rabies virus
Research brings better understanding of how disordered proteins contribute to the properties of the rabies virus
Breakthrough in understanding immune responses in inflammatory bowel and lung disease
Viralgen Vector Core and Elpida Therapeutics partner to manufacture gene therapy medicines for anticipated Spastic Paraplegia 50 (SPG50) and Charcot-Marie-Tooth disease type…
Starpharma announces the presentation of DEP irinotecan combination data
Improve use of medicines and medical tests with $26 million in grants
HealthTech InnovationAus award finalists announced
Research assistant Michael Hutton publishes review on atherosclerosis research
NIH Center grant bolsters male contraceptive research
New target to beat cancer drug resistance
Tiny fish could be key to develop treatment against MND
Australian-developed drug receives US FDA approval
Ultrathin nanotech promises to help tackle antibiotic resistance
Top Perth blood cancer researcher wins prestigious award
Non-animal models could deliver $1.5B growth
‘Introspective’ AI Finds Diversity Improves Performance
Nanoneedle breakthrough gives hope for cheaper cancer treatment
Nominations open for AusBiotech Board 22 August
Pill could provide alternative to weight loss surgery
A prescription product to help people at risk of dying by suicide
Fast Five with Jonathan Lozano-Salgado
Can the body’s signalling protein be harnessed to stop ovarian cancer?
Chimeric reports positive in-vitro data for CHM 0301 next-generation cell platform
Monash University and Moderna form partnership to advance homegrown mRNA medicines
Potential neuropathic pain treatment shows promise in preclinical tests
Australian vaccine breakthrough offers hope against EBV-associated cancers and MS
Universal siRNA Covid treatment shows promise in lab
Landmark public health decisions by WHO on essential medicines for alcohol use disorders
Researchers investigate new therapy to heal osteoporosis fractures
Scientists push boundaries in flu fight
New AusBiotech report shows increasing US investment in Australian biotechs
Allarity Therapeutics and FivepHusion announce collaboration for the development of Deflexifol with DRP Companion Diagnostics
Alexion, AstraZeneca Rare Disease, enters agreement with Pfizer to acquire a portfolio of preclinical rare disease gene therapies
Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients
Chimeric receives patent allowance for chlorotoxin in Japan
100 Future Fellows Awarded Funding
Improving health outcomes for people living with post-acute sequelae of COVID-19 (long COVID)
Promising new drug to manage high blood pressure
BioCurate in new partnership with the European Healthtech Venture Builder
Nonsense and quality control wins $US500,000
World first trial for kids with Duchenne Muscular Dystrophy
NSW new world first trial for kids with Duchenne Muscular Dystrophy
Restoring Lost Sense of Smell
Early-Stage Innovation Forum opens